Pod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc)
Loading...
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Open Access Color
Green Open Access
No
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
BIP! Indicators
Impulse
Average
Influence
Average
Popularity
Average
Abstract
Description
Bondarenko, Igor/0000-0002-7071-2471
ORCID
Keywords
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1
OpenCitations Citation Count
N/A
Source
European-Society-for-Medical-Oncology Asia Congress (ESMO) -- DEC 06-08, 2024 -- Singapore, SINGAPORE
Volume
35
Issue
Start Page
S1633
End Page
S1634
PlumX Metrics
Captures
Mendeley Readers : 1
Google Scholar™
